Journal
ANNALS OF NEUROLOGY
Volume 90, Issue 5, Pages 711-719Publisher
WILEY
DOI: 10.1002/ana.26187
Keywords
-
Categories
Ask authors/readers for more resources
Early differential diagnosis of Parkinson disease and atypical parkinsonism is challenging, but advancements in SPECT/PET molecular imaging offer potential for more accurate disease detection and earlier diagnosis. This review highlights the importance of integrating molecular imaging as a diagnostic technique in improving the diagnosis of neurodegenerative parkinsonism.
The early differential diagnosis of Parkinson disease and atypical parkinsonism is a major challenge. The use of single photon emission computed tomography (SPECT)/positron emission tomography (PET) molecular imaging to investigate parkinsonism is a fast-developing field. Imaging biomarker research may potentially lead to more accurate disease detection, enabling earlier diagnosis and treatment. This review summarizes recent SPECT/PET advances in radiopharmaceuticals and imaging technologies/analyses that improve the diagnosis of neurodegenerative parkinsonism. We are currently witnessing a turning point in the field. Integrating molecular imaging as a diagnostic technique represents an opportunity to reassess the strategies for diagnosing neurodegenerative parkinsonism. ANN NEUROL 2021
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available